How China Deals with Its Public Health Expenditure Amidst COVID-19 Pandemic?; Multinational Pharma Firms are Adjusting Their Strategic Thinking to Compete in China’s Expanding Pharmaceutical Market; Biomedical Industrial Parks Fueling a Biotech Boom in China; New Pilot Program on Public Health Insurance Payments Kicking off